Automated Author Profile

Langley, Richard G.

Current S-Index

9.0

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

1.8

Average Dataset Index per dataset

Total Datasets

5

Total datasets for this author

Average FAIR Score

73.1%

Average FAIR Score per dataset

Total Citations

0

Total citations to the author's datasets

Total Mentions

0

Total mentions of the author's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

Supplementary Appendix: Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial

Supplementary materials for the BE BRIGHT 4-Year Efficacy and Safety manuscript, including Plain Language Summary and supplementary methods, tables, and figures.

Authors

  • Blauvelt, Andrew ;
  • Langley, Richard G. ;
  • Lebwohl, Mark ;
  • Strober, Bruce ;
  • Warren, Richard ;
  • Puig, Lluis ;
  • Morita, Akimichi ;
  • Gordon, Kenneth B. ;
  • Fernandez-Peñas, Pablo ;
  • Kavanagh, Sarah ;
  • López Pinto, José M. ;
  • Lambert, Jérémy ;
  • Hoepken, Bengt ;
  • Deherder, Delphine ;
  • Cross, Nancy ;
  • Thaci, Diamant
0 Citations0 Mentions65% FAIR1.6 Dataset Index
10.17632/24zjytjd7zJune 2025

Supplementary Appendix: Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial

Supplementary materials for the BE BRIGHT 4-Year Efficacy and Safety manuscript, including Plain Language Summary and supplementary methods, tables, and figures.

Authors

  • Blauvelt, Andrew ;
  • Langley, Richard G. ;
  • Lebwohl, Mark ;
  • Strober, Bruce ;
  • Warren, Richard ;
  • Puig, Lluis ;
  • Morita, Akimichi ;
  • Gordon, Kenneth B. ;
  • Fernandez-Peñas, Pablo ;
  • Kavanagh, Sarah ;
  • López Pinto, José M. ;
  • Lambert, Jérémy ;
  • Hoepken, Bengt ;
  • Deherder, Delphine ;
  • Cross, Nancy ;
  • Thaci, Diamant
0 Citations0 Mentions65% FAIR1.6 Dataset Index
10.17632/24zjytjd7z.2June 2025

Supplementary Appendix: Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial

Supplementary materials for the BE BRIGHT 4-Year Efficacy and Safety manuscript, including Plain Language Summary and supplementary methods, tables, and figures.

Authors

  • Blauvelt, Andrew ;
  • Langley, Richard G. ;
  • Lebwohl, Mark ;
  • Strober, Bruce ;
  • Warren, Richard ;
  • Puig, Lluis ;
  • Morita, Akimichi ;
  • Gordon, Kenneth B. ;
  • Fernandez-Peñas, Pablo ;
  • Kavanagh, Sarah ;
  • López Pinto, José M. ;
  • Lambert, Jérémy ;
  • Hoepken, Bengt ;
  • Deherder, Delphine ;
  • Cross, Nancy ;
  • Thaci, Diamant
0 Citations0 Mentions65% FAIR1.6 Dataset Index
10.17632/24zjytjd7z.1April 2025

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

Article full text
The full text of this article can be found here. https://link.springer.com/article/10.1007/s13555-017-0211-4
Provide enhanced content for this article
If you are an author of this publication and would like to provide additional enhanced content for your article then please contact [email protected].
The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.
Other enhanced features include, but are not limited to:
• Slide decks • Videos and animations • Audio abstracts • Audio slides

Authors

  • Pariser, David ;
  • Frankel, Ellen ;
  • Schlessinger, Joel ;
  • Poulin, Yves ;
  • Vender, Ronald ;
  • Langley, Richard G. ;
  • Xiangyi Meng ;
  • Guana, Adriana ;
  • Nyirady, Judit
0 Citations0 Mentions85% FAIR2.1 Dataset Index
10.6084/m9.figshare.6022796January 2018

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

Article full text
The full text of this article can be found here. https://link.springer.com/article/10.1007/s13555-017-0211-4
Provide enhanced content for this article
If you are an author of this publication and would like to provide additional enhanced content for your article then please contact [email protected].
The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.
Other enhanced features include, but are not limited to:
• Slide decks • Videos and animations • Audio abstracts • Audio slides

Authors

  • Pariser, David ;
  • Frankel, Ellen ;
  • Schlessinger, Joel ;
  • Poulin, Yves ;
  • Vender, Ronald ;
  • Langley, Richard G. ;
  • Xiangyi Meng ;
  • Guana, Adriana ;
  • Nyirady, Judit
0 Citations0 Mentions85% FAIR2.1 Dataset Index
10.6084/m9.figshare.6022796.v1January 2018